BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND CCDC6, D10S170, 8030, ENSG00000108091, Q16204, TPC, H4, TST1
110 results:

  • 1. [Preparation and characterization of chicken anti-human B7-H4 IgY polyclonal antibody].
    Zhang L; Fan Z; Zhang W; Huang H; Wang J; Hei A; Cong Y; Xu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Mar; 40(3):257-266. PubMed ID: 38512036
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification of Germline
    Pires C; Saramago A; Moura MM; Li J; Donato S; Marques IJ; Belo H; Machado AC; Cabrera R; Grünewald TGP; Leite V; Cavaco BM
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396644
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Antibody-Drug Conjugates: Advancing from Magic Bullet to Biological Missile.
    Veneziani AC; Sneha S; Oza AM
    Clin Cancer Res; 2024 Apr; 30(8):1434-1437. PubMed ID: 38306232
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Modulatory effect of pomegranate peel extract on key regulators of ovarian cellular processes
    Kolesarova A; Baldovska S; Kohut L; Vasicek J; Ivanisova E; Arvay J; Duracka M; Roychoudhury S
    Front Endocrinol (Lausanne); 2023; 14():1277155. PubMed ID: 38027211
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A B7-H4-Targeting Antibody-Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant cancers with B7-H4 Expression.
    Gitto SB; Whicker M; Davies G; Kumar S; Kinneer K; Xu H; Lewis A; Mamidi S; Medvedev S; Kim H; Anderton J; Tang EJ; Ferman B; Coats S; Wilkinson RW; Brown E; Powell DJ; Simpkins F
    Clin Cancer Res; 2024 Apr; 30(8):1567-1581. PubMed ID: 37882675
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. SGN-B7H4V, an investigational vedotin ADC directed to the immune checkpoint ligand B7-H4, shows promising activity in preclinical models.
    Gray E; Ulrich M; Epp A; Younan P; Sahetya D; Hensley K; Allred S; Huang LY; Hahn J; Gahnberg K; Treuting PM; Trueblood ES; Gosink JJ; Thurman R; Wo S; Spahr K; Haass EJ; Snead K; Miller D; Padilla M; Smith AJ; Frantz C; Schrum JP; Nazarenko N; Gardai SJ
    J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37793853
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Platinum(IV)-Gold(I) Agents with Promising Anticancer Activity: Selected Studies in 2D and 3D Triple-Negative Breast cancer Models.
    López-Hernández JE; Nayeem N; Cerón-Carrasco JP; Ahad A; Hafeez A; León IE; Contel M
    Chemistry; 2023 Oct; 29(59):e202302045. PubMed ID: 37507346
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody-Drug Conjugate for the Treatment of cancer.
    Toader D; Fessler SP; Collins SD; Conlon PR; Bollu R; Catcott KC; Chin CN; Dirksen A; Du B; Duvall JR; Higgins S; Kozytska MV; Bellovoda K; Faircloth C; Lee D; Li F; Qin L; Routhier C; Shaw P; Stevenson CA; Wang J; Wongthida P; Ter-Ovanesyan E; Ditty E; Bradley SP; Xu L; Yin M; Yurkovetskiy AV; Mosher R; Damelin M; Lowinger TB
    Mol Cancer Ther; 2023 Sep; 22(9):999-1012. PubMed ID: 37294948
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Oncogene-mediated nuclear accumulation of lactate promotes epigenetic alterations to induce cancer cell proliferation.
    Bandopadhyay S; Kamal IM; Padmanaban E; Ghosh DD; Chakrabarti S; Roy SS
    J Cell Biochem; 2023 Apr; 124(4):495-519. PubMed ID: 36999756
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Olaparib efficacy in patients with germline BRCA-mutated, HER2-negative metastatic breast cancer: Subgroup analyses from the phase III OlympiAD trial.
    Senkus E; Delaloge S; Domchek SM; Conte P; Im SA; Xu B; Armstrong A; Masuda N; Fielding A; Robson M; Tung N
    Int J Cancer; 2023 Aug; 153(4):803-814. PubMed ID: 36971103
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Identification of antigenic epitopes recognized by tumor infiltrating lymphocytes in high grade serous ovarian cancer by multi-omics profiling of the auto-antigen repertoire.
    Millar DG; Yang SYC; Sayad A; Zhao Q; Nguyen LT; Warner K; Sangster AG; Nakatsugawa M; Murata K; Wang BX; Shaw P; Clarke B; Bernardini MQ; Pugh T; Thibault P; Hirano N; Perreault C; Ohashi PS
    Cancer Immunol Immunother; 2023 Jul; 72(7):2375-2392. PubMed ID: 36943460
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The stromal tumor-infiltrating lymphocytes, cancer stemness, epithelial-mesenchymal transition, and B7-H4 expression in ovarian serous carcinoma.
    Hwang C; Lee HJ; Na JY; Kim KH; Song YJ; Kim JY; Kim K; Shin DH; Park JY; Kim SY; Lee JH; Choi KU
    J Ovarian Res; 2023 Jan; 16(1):3. PubMed ID: 36609273
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Expression and significance of immune checkpoint B7-homolog 4 in endometrial cancer].
    Zong LJ; Xiang Y; Yu SN; Lu ZH; Chen J; Huang WH
    Zhonghua Fu Chan Ke Za Zhi; 2022 Dec; 57(12):921-931. PubMed ID: 36562226
    [No Abstract]    [Full Text] [Related]  

  • 14. The disruption of the ccdc6 - PP4 axis induces a BRCAness like phenotype and sensitivity to PARP inhibitors in high-grade serous ovarian carcinoma.
    Morra F; Merolla F; Damia G; Ricci F; Varricchio S; Ilardi G; Arenare L; Califano D; Napolitano V; Fruscio R; Melillo RM; Palazzo L; Celetti A
    J Exp Clin Cancer Res; 2022 Aug; 41(1):245. PubMed ID: 35964058
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Histone deacetylase inhibitor, panobinostat, exerts anti-proliferative effect with partial normalization from aberrant epigenetic states on granulosa cell tumor cell lines.
    Hazama Y; Tsujioka T; Kitanaka A; Tohyama K; Shimoya K
    PLoS One; 2022; 17(7):e0271245. PubMed ID: 35802681
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Expression pattern and prognostic potential of histamine receptors in epithelial ovarian cancer.
    Kraus FBT; Topalov NE; Deuster E; Hysenaj I; Mayr D; Chelariu-Raicu A; Beyer S; Kolben T; Burges A; Mahner S; Trillsch F; Jeschke U; Czogalla B
    J Cancer Res Clin Oncol; 2023 Jun; 149(6):2501-2511. PubMed ID: 35751684
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Oncohistone Mutations Occur at Functional Sites of Regulatory ADP-Ribosylation.
    Huang D; Camacho CV; Martire S; Nagari A; Setlem R; Gong X; Edwards AD; Chiu SP; Banaszynski LA; Kraus WL
    Cancer Res; 2022 Jul; 82(13):2361-2377. PubMed ID: 35472077
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Black coffee mitigates diethyl phthalate disrupted folliculogenesis, reduced gonadotropins, and ovarian lesions in female albino mice.
    Ara C; Asmatullah ; Ramzan N; Ali S; Shakir HA; Liaqat I; Iqbal A; Yaseen F; Shahzad N
    Environ Sci Pollut Res Int; 2022 Jul; 29(31):47254-47266. PubMed ID: 35182336
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. MiR-192-5p inhibits proliferation, migration, and invasion in papillary thyroid carcinoma cells by regulation of SH3RF3.
    Fu S; Ma C; Tang X; Ma X; Jing G; Zhao N; Ran J
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34486645
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Arf6-mediated macropinocytosis-enhanced suicide gene therapy of C16TAB-condensed Tat/pDNA nanoparticles in ovarian cancer.
    Sun Z; Huang J; Su L; Li J; Qi F; Su H; Chen Y; Zhang Q; Zhang Q; Li Z; Zhang S
    Nanoscale; 2021 Sep; 13(34):14538-14551. PubMed ID: 34473182
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.